Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Dextrose Injection for Sport-Limiting Osgood Schlatter Disease in Adolescents.

NCT01300754 is registered in ClinicalTrials.gov with Universidad Nacional de Rosario as lead sponsor.

NCT NCT01300754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01300754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Dextrose Injection for Sport-Limiting Osgood Schlatter Disease in Adolescents.
Lead sponsor
Universidad Nacional de Rosario
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2006
Completion date
September 30, 2010
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osgood-schlatter disease